These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. In vitro susceptibilities of 180 clinical isolates of Haemophilus influenzae to ampicillin, amoxycillin/clavulanate, cefaclor, cefuroxime, cefotaxime, clarithromycin, and azithromycin. Delmée M, Carpentier M, Glupczynski Y, Gordts B, Magerman K, Simon A, Surmont I, Van de Vyvere M, Van Landuyt H, Van Nimmen L, Van Noyen R. Acta Clin Belg; 1996; 51(4):237-43. PubMed ID: 8858889 [Abstract] [Full Text] [Related]
24. [Clinical evaluation of cefixime in pediatric respiratory tract infections]. Iwai N, Nakamura H, Kasai K, Ozaki T, Matsui Y, Tauchi N, Yamaguchi H, Taneda Y, Maki T. Jpn J Antibiot; 1991 Jan; 44(1):35-47. PubMed ID: 2041146 [Abstract] [Full Text] [Related]
31. Susceptibility of European beta-lactamase-positive and -negative Haemophilus influenzae isolates from the periods 1997/1998 and 2002/2003. Fluit AC, Florijn A, Verhoef J, Milatovic D. J Antimicrob Chemother; 2005 Jul; 56(1):133-8. PubMed ID: 15917287 [Abstract] [Full Text] [Related]
32. Comparative in vitro activity of imipenem against Haemophilus influenzae and Haemophilus parainfluenzae. Cerami AT, Shungu DL. Antimicrob Agents Chemother; 1986 Jul; 30(1):179-80. PubMed ID: 3489437 [Abstract] [Full Text] [Related]
33. Antibiotic susceptibility of type b Haemophilus influenzae and Streptococcus pneumoniae, and antibiotic concentration in cerebrospinal fluid. Fujita K, Zhang DH, Sakata H, Murono K, Kakehashi H, Yoshioka H. Acta Paediatr Jpn; 1990 Apr; 32(2):132-8. PubMed ID: 2116062 [Abstract] [Full Text] [Related]
34. Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acid. Barry AL, Fuchs PC, Pfaller MA. Antimicrob Agents Chemother; 1993 Jan; 37(1):14-8. PubMed ID: 8431012 [Abstract] [Full Text] [Related]
35. In vitro comparison of ampicillin-chloramphenicol and ampicillin-cefotaxime against 284 Haemophilus isolates. Lapointe JR, Lavallée C, Michaud A, Chicoine L, Joncas JH. Antimicrob Agents Chemother; 1986 Apr; 29(4):594-7. PubMed ID: 3486630 [Abstract] [Full Text] [Related]
37. Activities and postantibiotic effects of gemifloxacin compared to those of 11 other agents against Haemophilus influenzae and Moraxella catarrhalis. Davies TA, Kelly LM, Hoellman DB, Ednie LM, Clark CL, Bajaksouzian S, Jacobs MR, Appelbaum PC. Antimicrob Agents Chemother; 2000 Mar; 44(3):633-9. PubMed ID: 10681330 [Abstract] [Full Text] [Related]
38. In vitro activity of cefprozil (BMY 28100) and cefepime (BMY 28142) against Streptococcus pneumoniae, Branhamella catarrhalis, and Haemophilus influenzae, and provisional interpretive criteria for disk diffusion and dilution susceptibility tests with Haemophilus influenzae. Doern GV, Vautour R. Diagn Microbiol Infect Dis; 1992 Mar; 15(7):633-40. PubMed ID: 1424521 [Abstract] [Full Text] [Related]
39. Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks. Zerva L, Biedenbach DJ, Jones RN. J Clin Microbiol; 1996 Aug; 34(8):1970-4. PubMed ID: 8818892 [Abstract] [Full Text] [Related]
40. Antimicrobial activities and susceptibility testing considerations of ampicillin, cephalothin, cefaclor, and cefuroxime against invasive isolates of Haemophilus influenzae. Shelton MM, Welch DF. Chemotherapy; 1989 Aug; 35(2):88-94. PubMed ID: 2788068 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]